#AACE2021: Top 20-Cardiovascular Risk in Polycystic Ovarian Syndrome: When to Screen & How to Treat

Cardiovascular Risk in Polycystic Ovarian Syndrome: When to Screen & How to Treat

Video Transcription

Video Summary

In a video on cardiovascular risk and polycystic ovarian syndrome (PCOS), Dr. Margaret Lippincott discusses the relationship between PCOS and cardiovascular disease. She explains that PCOS is a polygenic disease with multiple genetic variants that predispose individuals to develop PCOS. These same genetic variants also increase the risk of obesity, hyperlipidemia, type 2 diabetes, and coronary artery disease. Dr. Lippincott emphasizes the importance of assessing cardiovascular disease risk in women with PCOS from an early age. This includes evaluating family history, lifestyle habits, blood pressure, BMI, waist circumference, glycemic markers, and lipid levels. Various risk calculations can be used to estimate the risk of developing cardiovascular disease over the lifetime or in the next 10 years. Treatment options for reducing cardiovascular disease risk in women with PCOS include lifestyle modifications, such as weight loss, a healthy diet, and exercise. Medications like metformin and liraglutide can also be considered. Dr. Lippincott highlights the need for regular monitoring and follow-up to ensure effective management of cardiovascular risk factors in women with PCOS.

Asset Subtitle

Margaret Lippincott, MD | Alice Y. Chang, MD, MSc

Keywords

PCOS

cardiovascular disease

genetic variants

obesity

hyperlipidemia

type 2 diabetes

coronary artery disease

risk calculations

treatment options